Australia News All stories

Dotz Nano (ASX:DTZ) announced a major leadership transition, with Nati Harpaz appointed as the company's new CEO, effective May 31.

BCAL Diagnostics (ASX:BDX) expands its cancer detection reach, integrating clinical referral forms into software used by 97% of Australian GPs.

Corazon Mining (ASX:CZN) has entered into a binding agreement to acquire 100% of the Chalice Gold Project from Westgold Resources (ASX:WGX).

Evergold Minerals (ASX:EG1) launched its 2026 exploration campaign, commencing reverse circulation drilling at the Mt Monger Gold Project.

BlinkLab (ASX:BB1) announced a landmark academic research agreement with the Erasmus University Medical Centre Rotterdam.

RBA minutes revealed a tight debate over the May cash rate decision before the central bank delivered a third consecutive hike to 4.35%.

The Australian Treasurer has issued new disposal orders targeting six foreign investors holding a combined 17.58% stake in Northern Minerals (ASX:NTU).

Synertec (ASX:SOP) executed a letter of intent with an Australian energy operator to initiate Phase 1 of an operational technology and digital systems project.

CuFe (ASX:CUF) executed a share subscription agreement with Tennant Consolidated Mining Group, a wholly owned subsidiary of Pan African Resources.

Dalaroo Metals (ASX:DAL) expanded its international footprint after announcing a major tenure expansion at its flagship Blue Lagoon Project.

American Tungsten & Antimony (ASX:AT4) has secured $10 million through a firm share placement to accelerate its critical minerals strategy in the US.

Leeuwin Metals (ASX:LM1) commenced a 5,000-metre high-impact reverse circulation drilling programme at its Marda Gold Project.

European Lithium (ASX:EUR) entered into a binding scheme implementation deed with Critical Metals Corp. (NASDAQ:CRML).

Koonenberry Gold (ASX:KNB) entered into a binding agreement to acquire the Gundagai Gold-Copper Project from Gilmore Minerals.

Amplia Therapeutics (ASX:ATX) initiated the first stage of a registration-enabling Phase 2b clinical trial for its drug candidate, narmafotinib.

TechnologyOne (ASX:TNE) has announced its financial results for the half-year ended March 31.

ASX-listed global money transfer company OFX Group (ASX:OFX) reported a challenging financial year ended March 31.

Parkway (ASX:PWN) has executed a binding memorandum of understanding with technology firm Hitachi.

Miramar Resources (ASX:M2R) said exploration activities have commenced at the Chain Pool Base and Precious Metals Project.

Maritana Minerals (ASX:MRT) has secured a dual tenement transaction with Accelerate Resources (ASX:AX8), executing an asset swap.

Telix Pharmaceuticals (ASX:TLX) completed patient enrolment for its international, multicentre Phase 1 IPAX-2 clinical trial.

Jim Chalmers will deploy fresh Treasury analysis to quell an investor outcry over federal budget changes to capital gains tax.

Mineral Resources (ASX:MIN) is set to dust off its mothballed Bald Hill lithium mine in the Goldfields, triggering a recruitment drive.

Federal budget trust tax hikes are forcing 350,000 Australian small businesses to restructure, triggering a massive state stamp duty crisis.